Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.
Over the last 12 months, insiders at Tempest Therapeutics, Inc. have bought $0 and sold $0 worth of Tempest Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Tempest Therapeutics, Inc. have bought $5.02M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,118,644 shares for transaction amount of $5M was made by Woiwode Thomas () on 2022‑04‑29.
2022-04-29 | Woiwode Thomas | 2.12M 11.9674% | $2.36 | $5M | -44.60% | |||
2022-01-07 | Dubensky Thomas W. | President | 2,000 0.0288% | $4.78 | $9,560 | -47.68% | ||
2022-01-06 | Whiting Samuel | Chief Medical Officer | 1,700 0.0243% | $4.80 | $8,168 | -48.40% | ||
2016-06-01 | Dipp Michelle | Chief Executive Officer | 425,000 1.3568% | $7.00 | $2.98M | -53.63% | ||
2016-06-01 | ALDRICH RICHARD | director | 425,000 1.3568% | $7.00 | $2.98M | -53.63% | ||
2016-05-18 | Dipp Michelle | Chief Executive Officer | 20,000 0.0671% | $7.86 | $157,200 | -53.14% | ||
2016-05-18 | ALDRICH RICHARD | director | 20,000 0.0671% | $7.86 | $157,200 | -53.14% | ||
2016-05-17 | Dipp Michelle | Chief Executive Officer | 20,000 0.0677% | $7.56 | $151,200 | -50.67% | ||
2016-05-17 | ALDRICH RICHARD | director | 20,000 0.0677% | $7.56 | $151,200 | -50.67% | ||
2016-05-16 | Dipp Michelle | Chief Executive Officer | 20,000 0.0668% | $7.69 | $153,800 | -51.69% | ||
2016-05-13 | Dipp Michelle | Chief Executive Officer | 16,295 0.055% | $7.06 | $115,043 | -46.48% | ||
2016-05-13 | ALDRICH RICHARD | director | 16,295 0.055% | $7.06 | $115,043 | -46.48% | ||
2016-05-12 | Dipp Michelle | Chief Executive Officer | 19,800 0.0679% | $6.84 | $135,352 | -43.52% | ||
2016-05-12 | ALDRICH RICHARD | director | 19,800 0.0679% | $6.84 | $135,352 | -43.52% | ||
2016-05-11 | Dipp Michelle | Chief Executive Officer | 20,000 0.0709% | $7.64 | $152,800 | -47.08% | ||
2016-05-11 | ALDRICH RICHARD | director | 20,000 0.0709% | $7.64 | $152,800 | -47.08% | ||
2016-05-10 | Dipp Michelle | Chief Executive Officer | 19,900 0.0647% | $7.72 | $153,628 | -51.08% | ||
2016-05-10 | ALDRICH RICHARD | director | 19,900 0.0647% | $7.72 | $153,628 | -51.08% | ||
2016-05-10 | CHAPMAN PAUL W.D. | Chief Operating Officer | 3,100 0.0096% | $7.37 | $22,847 | -51.08% | ||
2016-03-24 | Dipp Michelle | Chief Executive Officer | 30,000 0.1018% | $9.23 | $276,906 | -40.12% |
Longwood Fund, L.P. | 10 percent owner | 3820571 19.8497% | $2.16 | 2 | 0 | |
Westphal Christoph H | 3820571 19.8497% | $2.16 | 2 | 0 | ||
Woiwode Thomas | 2118644 11.0074% | $2.16 | 1 | 0 | <0.0001% | |
Dipp Michelle | Chief Executive Officer | 962056 4.9983% | $2.16 | 29 | 0 | <0.0001% |
ALDRICH RICHARD | director | 962056 4.9983% | $2.16 | 29 | 0 | <0.0001% |
Malley Thomas | director | 122200 0.6349% | $2.16 | 3 | 0 | <0.0001% |
Dubensky Thomas W. | President | 113343 0.5889% | $2.16 | 1 | 0 | <0.0001% |
KOZIN MARC D | director | 20553 0.1068% | $2.16 | 3 | 0 | <0.0001% |
Stock Harald F. | director | 13022 0.0677% | $2.16 | 10 | 0 | |
CAPELLO JEFFREY D | director | 11111 0.0577% | $2.16 | 1 | 0 | |
FISHER MARY | director | 6415 0.0333% | $2.16 | 1 | 0 | <0.0001% |
Young Jeffrey E | Chief Financial Officer | 3750 0.0195% | $2.16 | 2 | 0 | <0.0001% |
CHAPMAN PAUL W.D. | Chief Operating Officer | 3100 0.0161% | $2.16 | 1 | 0 | <0.0001% |
Harding David | Chief Commercial Officer | 2290 0.0119% | $2.16 | 1 | 0 | |
BLECK CHRISTOPHER A | Chief Commercial Officer | 2000 0.0104% | $2.16 | 1 | 0 | |
Whiting Samuel | Chief Medical Officer | 1901 0.0099% | $2.16 | 1 | 0 | <0.0001% |
McNeely Theresa | EVP, Chief Comm. Officer | 400 0.0021% | $2.16 | 2 | 0 | <0.0001% |
TZIANABOS ARTHUR | President and CSO | 400 0.0021% | $2.16 | 3 | 0 | <0.0001% |
BlackRock | $1.99M | 2.29 | 508,195 | -0.14% | -$2,866.03 | <0.0001 | |
Fidelity Investments | $1.69M | 1.94 | 431,982 | +0.01% | +$195.50 | <0.0001 | |
The Vanguard Group | $688,914.00 | 0.79 | 176,193 | 0% | +$0 | <0.0001 | |
Geode Capital Management | $516,519.00 | 0.6 | 132,083 | +4.9% | +$24,108.63 | <0.0001 | |
Fil Ltd | $506,654.00 | 0.58 | 129,579 | 0% | +$0 | <0.0001 | |
Ikarian Capital LLC | $412,895.00 | 0.48 | 105,600 | 0% | +$0 | 0.12 | |
Bank of America | $168,243.00 | 0.19 | 43,029 | +14.86% | +$21,766.92 | <0.0001 | |
State Street | $162,234.00 | 0.19 | 41,492 | +76.62% | +$70,380.12 | <0.0001 | |
Simplex Trading Llc | $147,000.00 | 0.17 | 37,820 | -43.92% | -$115,108.54 | <0.01 | |
Morgan Stanley | $143,853.00 | 0.17 | 36,791 | +15.64% | +$19,452.28 | <0.0001 | |
Virtu Financial Llc | $112,000.00 | 0.13 | 28,574 | +69.23% | +$45,816.76 | 0.01 | |
Advisor Group Holdings Inc | $102,232.00 | 0.12 | 26,150 | 0% | +$0 | <0.0001 | |
Boothbay Fund Management LLC | $96,077.00 | 0.11 | 24,572 | 0% | +$0 | <0.01 | |
Susquehanna International Group | $90,552.00 | 0.1 | 23,159 | -77.82% | -$317,676.86 | <0.0001 | |
Jane Street Capital | $82,251.00 | 0.1 | 21,036 | New | +$82,251.00 | <0.0001 | |
Northern Trust | $79,588.00 | 0.09 | 20,355 | -39.42% | -$51,780.10 | <0.0001 | |
Bank of Montreal | $78,800.00 | 0.09 | 20,000 | +100% | +$39,400.00 | <0.0001 | |
Tocqueville Asset Management | $54,740.00 | 0.06 | 14,000 | 0% | +$0 | <0.01 | |
Hrt Financial Llc | $50,000.00 | 0.06 | 13,040 | New | +$50,000.00 | <0.0001 | |
Xtx Topco Ltd | $42,122.00 | 0.05 | 10,773 | New | +$42,122.00 | <0.01 | |
Group One Trading | $41,778.00 | 0.05 | 10,685 | -48.4% | -$39,181.78 | <0.01 | |
Tower Research Capital | $31,260.00 | 0.04 | 7,995 | +643.03% | +$27,052.90 | <0.0001 | |
UBS | $3,601.00 | <0.01 | 921 | +246.24% | +$2,560.97 | <0.0001 | |
Cibc Private Wealth Group Llc | $724.00 | <0.01 | 133 | New | +$724.00 | <0.0001 | |
Cutler Group Lp | $0 | <0.01 | 210 | -98.37% | -$0 | <0.0001 | |
Whittier Trust Company | $7.00 | <0.01 | 2 | 0% | +$0 | <0.0001 | |
Citadel Advisors LLC | $12.00 | <0.01 | 3 | New | +$12.00 | <0.0001 | |
Whittier Trust Co Of Nevada Inc | $42.00 | <0.01 | 11 | 0% | +$0 | <0.0001 | |
Wells Fargo | $383.00 | <0.01 | 98 | +2.08% | +$7.82 | <0.0001 | |
Qube Research & Technologies | $106.00 | <0.01 | 27 | 0% | +$0 | <0.0001 |